- Home
- Equipment
- usa georgia
- drug developers
Show results for
Refine by
Drug Developers Equipment Supplied In Usa Georgia
9 equipment items found
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
Agonist refers to substances that activate a specific target protein. It can easily be viewed as the opposite of inhibitor. Until now, Deargen's drug-target interaction (DTI) was predicted based on the binding affinity between the substance and the target protein, which causes barrier to distinguish between the inhibition and activation activity. In addition, the demand for ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
PROTAC is composed of a protein of interest, a ligand that binds to the E3 ligase, and a linker that connects the two. PROTAC is emerging as a next-generation platform for new drug development that overcomes the problems of drug resistance and “Undruggable targets” of existing target therapies whose main purpose was to inhibit the ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
MolEQ designs novel compounds by optimizing multiple properties such as efficacy and toxicity of a lead ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
To hinder or inhibit the function of proteins that cause disease, many pharmaceutical companies develop drugs called inhibitors. Each of the 20,000 proteins in the human body has its own unique functions. Depending on the function of the protein, it can be classified into enzyme proteins, ion channel proteins, transport proteins, defense proteins, and structural ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
DearDTI presents drug candidates with a good efficacy by predicting the binding affinity, based on information about the compound-protein ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
WX presents biomarkers, based on raw transcriptome data. It is an artificial intelligence technology that can predict biomarkers, prognostic biomarkers and even the mode of action (MOA) of disease ...
by:DEARGEN Inc. based inDaejeon, SOUTH KOREA
Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for new ...
Manufactured by:RayBiotech Life, Inc. based inPeachtree Corners, GEORGIA (US) (USA)
Combining direct antigen-labeling technology with our vast library of array-validated antibodies, RayBiotech has created our largest antibody array to date: the Human L6000 Array. With the L-Series high density array platform, researchers can now detect up to 6000 proteins simultaneously, obtaining a broad, panoramic view of protein expression. Our newly expanded panel includes a wide variety of ...
Manufactured by:RayBiotech Life, Inc. based inPeachtree Corners, GEORGIA (US) (USA)
Semi-Quantitative, Sandwich-Based, Membrane Antibody Arrays. The RayBio® Membrane-Based Antibody Arrays (C-Series) are tools for screening and comparing expression levels of many cytokines, growth factors, proteases, soluble receptors, and other proteins in a wide variety of sample types. The C-Series Arrays utilize the sandwich immunoassay principle, wherein a panel of capture antibodies is ...